Gamco Investors INC. ET AL reduced its stake in Align Technology, Inc. (NASDAQ:ALGN) by 20.0% during the 4th quarter, HoldingsChannel reports. The fund owned 1,200 shares of the medical equipment provider’s stock after selling 300 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Align Technology were worth $267,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in ALGN. Whittier Trust Co. acquired a new stake in shares of Align Technology in the third quarter valued at $107,000. Meritage Portfolio Management acquired a new stake in shares of Align Technology in the fourth quarter valued at $201,000. Dai Ichi Life Insurance Company Ltd acquired a new stake in shares of Align Technology in the third quarter valued at $211,000. Sigma Investment Counselors Inc. acquired a new stake in shares of Align Technology in the third quarter valued at $214,000. Finally, Ballentine Partners LLC acquired a new stake in shares of Align Technology in the third quarter valued at $215,000. Institutional investors and hedge funds own 81.99% of the company’s stock.

Several equities analysts recently commented on the company. BidaskClub lowered Align Technology from a “buy” rating to a “hold” rating in a report on Friday, February 9th. Stifel Nicolaus reissued a “buy” rating and issued a $225.00 target price (up previously from $205.00) on shares of Align Technology in a report on Thursday, October 19th. Robert W. Baird set a $208.00 target price on Align Technology and gave the company a “buy” rating in a report on Wednesday, October 18th. Piper Jaffray Companies reissued a “buy” rating and issued a $300.00 target price on shares of Align Technology in a report on Wednesday, January 31st. Finally, Credit Suisse Group increased their target price on Align Technology from $276.00 to $290.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $258.54.

In other Align Technology news, VP Emory Wright sold 5,025 shares of the firm’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $263.68, for a total transaction of $1,324,992.00. Following the transaction, the vice president now owns 80,762 shares of the company’s stock, valued at $21,295,324.16. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO John Morici sold 1,500 shares of the firm’s stock in a transaction dated Friday, November 24th. The stock was sold at an average price of $255.00, for a total value of $382,500.00. Following the transaction, the chief financial officer now directly owns 1,544 shares in the company, valued at approximately $393,720. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 82,029 shares of company stock worth $21,369,243. Corporate insiders own 1.60% of the company’s stock.

Align Technology, Inc. (ALGN) opened at $233.73 on Wednesday. The company has a market capitalization of $18,691.83, a price-to-earnings ratio of 82.30, a P/E/G ratio of 1.78 and a beta of 1.48. Align Technology, Inc. has a twelve month low of $97.31 and a twelve month high of $287.32.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings data on Tuesday, January 30th. The medical equipment provider reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.23. The company had revenue of $421.30 million for the quarter, compared to analyst estimates of $395.88 million. Align Technology had a return on equity of 28.55% and a net margin of 15.71%. The business’s quarterly revenue was up 43.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.59 earnings per share. analysts anticipate that Align Technology, Inc. will post 4.49 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://theolympiareport.com/2018/02/14/gamco-investors-inc-et-al-has-267000-stake-in-align-technology-inc-algn.html.

Align Technology Profile

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.